BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:SPT-300 (GlyphAllo (allopregnanolone prodrug)) readouts · Ass
 etMemo
X-WR-CALDESC:Upcoming readouts of SPT-300 (GlyphAllo (allopregnanolone prod
 rug))\, from ClinicalTrials.gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07065240-865@assetmemo.bio
DTSTAMP:20261121T010453Z
DTSTART;VALUE=DATE:20270331
DTEND;VALUE=DATE:20270401
SUMMARY:SPT-300 (GlyphAllo (allopregnanolone prodrug)): Phase 2 readout est
 . (NCT07065240)
DESCRIPTION:SPT-300 (GlyphAllo (allopregnanolone prodrug))\, phase 2\, Majo
 r Depressive Disorder.\nStudy: A Study to Evaluate the Efficacy and Safety
  of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder\, W
 ith or Without Anxious Distress (BUOY-1 Study)\nEstimated primary completi
 on: March 2027. This is a ClinicalTrials.gov estimate\, not a confirmed re
 adout date\, and it can move.\nDrug page: https://assetmemo.bio/drug/glyph
 allo-allopregnanolone-prodrug#upcoming-events\nRegistry record: https://cl
 inicaltrials.gov/study/NCT07065240
URL:https://assetmemo.bio/drug/glyphallo-allopregnanolone-prodrug#upcoming-
 events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07161700-865@assetmemo.bio
DTSTAMP:20261121T010453Z
DTSTART;VALUE=DATE:20270531
DTEND;VALUE=DATE:20270601
SUMMARY:SPT-300 (GlyphAllo (allopregnanolone prodrug)): Phase 2 readout est
 . (NCT07161700)
DESCRIPTION:SPT-300 (GlyphAllo (allopregnanolone prodrug))\, phase 2\, Majo
 r Depressive Disorder.\nStudy: An Open-Label Extension Study to Evaluate t
 he Safety and Tolerability of SPT-300 (GlyphAllo) in Participants With Maj
 or Depressive Disorder\, With or Without Anxious Distress (BUOY-1 OLE Stud
 y)\nEstimated primary completion: May 2027. This is a ClinicalTrials.gov e
 stimate\, not a confirmed readout date\, and it can move.\nDrug page: http
 s://assetmemo.bio/drug/glyphallo-allopregnanolone-prodrug#upcoming-events\
 nRegistry record: https://clinicaltrials.gov/study/NCT07161700
URL:https://assetmemo.bio/drug/glyphallo-allopregnanolone-prodrug#upcoming-
 events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
